You searched for "medicines"
Decoding the red eye
Red eye, or hyperaemia, is one of the most common presentations to primary care [1] and the emergency department [2]. However, despite this the underlying cause is often misdiagnosed which can lead to severe, sight-threatening conditions being missed [1]. Thorough...The screening and treatment of retinopathy of prematurity
A male child is born at 31 weeks and requires 100% oxygen supplementation with intensive care. What would be the ophthalmic management of this child? In the first instance, it will be useful to know the screening criteria and protocol....Preparing for modern ophthalmic surgical training as a trainee
As a trainee in ophthalmology, every day you are learning more and more about the specialty. In addition, you will most likely be exploring the vast array of subspecialties that ophthalmology has to offer, and would probably be trying to...How to maximise points for your ophthalmology portfolio as a medical student
Ophthalmology is an extremely popular and competitive career option, with one of the highest competition ratios at ST1 level entry (10:1 in 2023) [1]. It is also a highly rewarding speciality, involving: a mixture of medicine and surgery in a...The Eyes Have It and World Eye Health Day - A Q&A with Marsha de Cordova
Westminster Eye Health Day is the flagship parliamentary event of The Eyes have It, a partnership of Roche, Macular Society, Fight for Sight, The Royal College of Ophthalmologists, Association of Optometrists and RNIB and has returned for its third year, sponsored by Marsha de Cordova MP.
Therapeutic options for advanced cutaneous basal (BCC) and squamous cell carcinomas (SCC)
This article discusses the use of topical and systemic therapy in the management of advanced periocular tumours. It focuses on those that have gained United States Food and Drug Administration approval; namely imiquimod, vismodegib, sonidegib, pembrolizumab and cemiplimab. Imiquimod is...
Uveitis and juvenile arthritis costs
The purpose of this study was to evaluate whether cost, prior insurance authorisation concerns and subspecialty practice influence therapeutic decisions in the treatment of uveitis associated with JIA. The authors developed an email questionnaire that included a brief vignette of...
